Compare Novartis with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs A-1 ACID - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS A-1 ACID NOVARTIS/
A-1 ACID
 
P/E (TTM) x 88.8 - - View Chart
P/BV x 2.8 5.0 56.4% View Chart
Dividend Yield % 1.2 0.0 -  

Financials

 NOVARTIS   A-1 ACID
EQUITY SHARE DATA
    NOVARTIS
Mar-21
A-1 ACID
Mar-20
NOVARTIS/
A-1 ACID
5-Yr Chart
Click to enlarge
High Rs77064 1,203.1%   
Low Rs50148 1,036.2%   
Sales per share (Unadj.) Rs154.5121.5 127.1%  
Earnings per share (Unadj.) Rs8.53.1 272.7%  
Cash flow per share (Unadj.) Rs13.45.9 228.5%  
Dividends per share (Unadj.) Rs10.000-  
Avg Dividend yield %1.60-  
Book value per share (Unadj.) Rs289.237.8 765.8%  
Shares outstanding (eoy) m24.6910.00 246.9%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x4.10.5 889.8%   
Avg P/E ratio x75.118.1 414.8%  
P/CF ratio (eoy) x47.59.6 495.0%  
Price / Book Value ratio x2.21.5 147.7%  
Dividend payout %118.10-   
Avg Mkt Cap Rs m15,691562 2,793.2%   
No. of employees `000NANA-   
Total wages/salary Rs m1,08510 10,818.5%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m3,8141,215 313.9%  
Other income Rs m332121 273.8%   
Total revenues Rs m4,1461,336 310.3%   
Gross profit Rs m267-43 -623.8%  
Depreciation Rs m12228 441.4%   
Interest Rs m7710 755.9%   
Profit before tax Rs m40041 982.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m19110 1,969.1%   
Profit after tax Rs m20931 673.3%  
Gross profit margin %7.0-3.5 -198.7%  
Effective tax rate %47.823.9 200.4%   
Net profit margin %5.52.6 214.5%  
BALANCE SHEET DATA
Current assets Rs m9,224355 2,599.2%   
Current liabilities Rs m3,57383 4,305.9%   
Net working cap to sales %148.222.4 662.1%  
Current ratio x2.64.3 60.4%  
Inventory Days Days1767 2,446.4%  
Debtors Days Days3778 47.6%  
Net fixed assets Rs m2,480149 1,667.1%   
Share capital Rs m123100 123.4%   
"Free" reserves Rs m7,018278 2,527.1%   
Net worth Rs m7,141378 1,890.7%   
Long term debt Rs m035 0.0%   
Total assets Rs m11,703504 2,323.9%  
Interest coverage x6.25.0 124.0%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.32.4 13.5%   
Return on assets %2.48.2 29.9%  
Return on equity %2.98.2 35.6%  
Return on capital %6.712.3 54.1%  
Exports to sales %9.30-   
Imports to sales %00-   
Exports (fob) Rs m354NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3540-   
Fx outflow Rs m9740-   
Net fx Rs m-6210-   
CASH FLOW
From Operations Rs m-692100 -691.8%  
From Investments Rs m952-3 -27,988.2%  
From Financial Activity Rs m-368-95 386.0%  
Net Cashflow Rs m-1091 -8,282.4%  

Share Holding

Indian Promoters % 0.0 70.0 -  
Foreign collaborators % 73.4 0.0 -  
Indian inst/Mut Fund % 1.3 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 26.6 30.0 88.7%  
Shareholders   44,652 270 16,537.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   BANGALORE FORT FARMS  ACE MEN ENG  SERVOTECH ENGG  DHAN ROTO SP  AKM LACE AND EMBROTEX  



Today's Market

Sensex Ends Above 60,000-Mark, Nifty Tops 17,850; Asian Paints & Eicher Motors Climb 3%(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Related Views on News

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

More Views on News

Most Popular

5 Specialty Chemical Stocks that Turned Multibaggers in One Year(Views On News)

Sep 17, 2021

These specialty chemical stocks have surged 200% or more in the last year. Do you own any?

A Rare Buying Opportunity in an Exciting Stock(Profit Hunter)

Sep 16, 2021

Whether agriculture sector goes through a structural transformation or not, this agrochemical stock has a good chance of winning.

5 Indian Companies with Over 7% in Dividend Yield(Views On News)

Sep 17, 2021

These stocks will give you better yields than bank deposits.

A Great Time to Buy ITC(Profit Hunter)

Sep 17, 2021

Is the worst over for the stock of ITC?

Top Small Caps to Buy Now(Views On News)

Sep 18, 2021

Rahul Shah on why he would invest in these unusual 20 small cap stocks

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Sep 24, 2021 (Close)

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NOVARTIS - PHARMAIDS PH COMPARISON

COMPARE NOVARTIS WITH

MARKET STATS